Abstract
IntroductionLack of comparative trial data on dosing regimens of infliximab rescue therapy in acute severe ulcerative colitis (ASUC) has resulted in variable use of rescue regimes in ASUC with potential...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
